UCSF School of Pharmacy faculty member Zev Gartner, PhD, will be co-director of a new multi-institution UCSF-administered Center for Cellular Construction, which has been awarded a five-year $24 million grant by the National Science Foundation (NSF).
UCSF School of Pharmacy faculty member Tejal Desai, PhD, has been newly elected to the National Academy of Medicine (NAM), formerly known as the Institute of Medicine (IOM).
NAM membership is considered one of the highest honors in health and medicine. Elected by current members, the membership recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health.
My research aims to improve the way we can “see” physiologic and metabolic activities in the body in real time, so that we can better understand normal physiology and clarify the underlying mechanisms of disease progression and response to therapy. To this end, I focus on developing novel strategies for obtaining and interpreting magnetic resonance data.
I am a biophysicist. My research is focused on discovering the macromolecular structure and dynamics of proteins—defining conformational states essential for function and understanding transitions between these states.
I am a bioengineer focusing on micro and nanofabrication techniques to create new devices for drug and cell delivery as well as biomaterials for cell and tissue regeneration. I also chair the Department of Bioengineering and Therapeutic Sciences.
I am a bioengineer working on medical device development to address clinical needs by leveraging my background in MEMS (microelectromechanical systems) along with advances in biomaterials, electronics, and nanotechnology to advance health world-wide.
I am an Assistant Professor studying patterns of human genetic variation from global populations using large-scale whole genome sequencing data in order to understand genetic susceptibility to disease and drug response.
My research focuses on membrane transporters, which are of great importance to drug disposition and response. I am particularly interested in genetic variants in membrane transporters that are determinants of drug response and in harnessing transporters to enhance drug targeting.